Fucoxanthinol and amarouciaxanthin accentuates these anti-obesity actions of fucoxanthin in later stages of adipocyte differentiation by suppressing PPARγ expression and glucose uptake (Kang et al., 2011). Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.